Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

30th Annual GP₂A Medicinal Chemistry Conference.

ABSTRACT: The Group for the Promotion of Pharmaceutical Chemistry in Academia (GP₂A) held their 30th annual conference in August 2022 in Trinity College Dublin, Ireland. There were 9 keynote presentations, 10 early career researcher presentations and 41 poster presentations.

SUBMITTER: O'Boyle NM

PROVIDER: S-EPMC10056312 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

30th Annual GP<sub>2</sub>A Medicinal Chemistry Conference.

O'Boyle Niamh M NM Helesbeux Jean-Jacques JJ Meegan Mary J MJ Sasse Astrid A O'Shaughnessy Elizabeth E Qaisar Alina A Clancy Aoife A McCarthy Florence F Marchand Pascal P

Pharmaceuticals (Basel, Switzerland) 20230312 3

The Group for the Promotion of Pharmaceutical Chemistry in Academia (GP<sub>2</sub>A) held their 30th annual conference in August 2022 in Trinity College Dublin, Ireland. There were 9 keynote presentations, 10 early career researcher presentations and 41 poster presentations. ...[more]

PMID: 36986531

Similar Datasets

29th Annual GP2A Medicinal Chemistry Conference.

Project description:The 29th Annual GP2A (Group for the Promotion of Pharmaceutical chemistry in Academia) Conference was a virtual event this year due to the COVID-19 pandemic and spanned three days from Wednesday 25 to Friday 27 August 2021. The meeting brought together an international delegation of researchers with interests in medicinal chemistry and interfacing disciplines. Abstracts of keynote lectures given by the 10 invited speakers, along with those of the 8 young researcher talks and the 50 flash presentation posters, are included in this report. Like previous editions, the conference was a real success, with high-level scientific discussions on cutting-edge advances in the fields of pharmaceutical chemistry.

| S-EPMC8708472 | biostudies-literature

26th Annual GP2A Medicinal Chemistry Conference & 32nd Journees Franco-Belges de Pharmacochimie.

Project description:As a joint meeting, the 26th Medicinal Chemistry Conference of GP2A and 32nd Journées Franco-Belges de Pharmacochimie took place between 13th and 15th June at Asnelles sur Mer (Normandie, France), providing a unique opportunity for a wide group of European medicinal chemists to engage. Topics included chemical tools for medicinal chemistry, protein-protein interactions, epigenetics, natural product-inspired molecules, computer-aided drug design, and new strategies for the design and development of drugs. Abstracts of invited lectures, proffered young researcher communications, flash communications and posters presented during the meeting are collected in this report.

| S-EPMC6630807 | biostudies-literature

Third International Electronic Conference on Medicinal Chemistry (ECMC-3).

Project description:The third International Electronic Conference on Medicinal Chemistry, organized and sponsored by MDPI AG, publisher, and the journal Pharmaceuticals, took place in November 2017 on the SciForum website (www.sciforum.net/conference/ecmc-3). Around 300 authors from 34 different countries participated at the event, which hosted more than 70 presentations, keynotes, videos, and posters. A short description of some works presented during that scientific meeting is disclosed in this report.

| S-EPMC5874714 | biostudies-literature

2020 Annual Conference Conference Annuelle.

Project description: Not available

| S-EPMC9632078 | biostudies-literature

30th Annual Computational Neuroscience Meeting: CNS*2021-Meeting Abstracts.

Project description: Not available

| S-EPMC8687879 | biostudies-literature

XLI Annual Meeting of the Indian Academy of Neurosciences and International Conference on BRAIN: CHEMISTRY TO COGNITION

Project description: Not available

| S-EPMC10829571 | biostudies-literature

First annual Canadian Cardiac Oncology Network conference.

Project description:The inaugural Canadian Cardiac Oncology Network conference was held at the Ottawa Convention Centre, Ottawa, Ontario, May 13, 2011. The learning objectives of the meeting were tounderstand and appreciate the importance of cardiac toxicity in the treatment of cancer patients.review current guidelines, recommendations, and ways to prevent and treat cardiac toxicity in cancer patients.develop potential research initiatives and collaboration across Canada.Although the cardiac toxicities associated with conventional systemic therapy agents are well established, the short- and long-term cardiac toxicities associated with targeted agents are less understood. In addition, the effects of exposing patients to multiple targeted therapies, and potentially compounding multiple cardiac toxicities, are unknown. This meeting report includes highlights from presentations at the conference.

| S-EPMC3224031 | biostudies-other

Probing the Allosteric Modulation of P-Glycoprotein: A Medicinal Chemistry Approach Toward the Identification of Noncompetitive P-Gp Inhibitors.

Project description:A medicinal chemistry approach combining in silico and in vitro methodologies was performed aiming at identifying and characterizing putative allosteric drug-binding sites (aDBSs) at the interface of the transmembrane- and nucleotide-binding domains (TMD-NBD) of P-glycoprotein. Two aDBSs were identified, one in TMD1/NBD1 and another one in TMD2/NBD2, by means of in silico fragment-based molecular dynamics and characterized in terms of size, polarity, and lining residues. From a small library of thioxanthone and flavanone derivatives, experimentally described to bind at the TMD-NBD interfaces, several compounds were identified to be able to decrease the verapamil-stimulated ATPase activity. An IC50 of 81 ± 6.6 μM is reported for a flavanone derivative in the ATPase assays, providing evidence for an allosteric efflux modulation in P-glycoprotein. Molecular docking and molecular dynamics gave additional insights on the binding mode on how flavanone derivatives may act as allosteric inhibitors.

| S-EPMC10061618 | biostudies-literature

Canadian Paediatric Society 92nd Annual Conference: Abstracts

Project description: Not available

| S-EPMC4472060 | biostudies-literature

Epigenetic Medicinal Chemistry.

Project description:The past decade has seen tremendous growth in our understanding of epigenetics and chromatin remodeling. Small, organic molecule modulators of a number of chromatin modifying proteins (CMPs) have been reported over this time frame and several of these have advanced to human clinical trials. In this Viewpoint, I summarize the current state of medicinal chemistry efforts focused on epigenetic targets and attempt to provide some insight into future directions on which the community may wish to focus.

| S-EPMC4753546 | biostudies-literature